Komori
Treasury shares4547KISSEI PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Regarding the Purchase of Treasury Shares Through an Off-Auction Purchase (ToSTNeT-3)

Regarding the treasury share acquisition resolved in May, the company decided on the specific method of purchasing the shares through ToSTNeT-3 on 5 November. The acquisition limit has been reduced from the initial limit and is set at 1,100,000 shares and ¥4.1305 billion.

Worth reading
59In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1100000
Shares (maximum)
Wording
Conditional
How definitive the wording is.

Resolution on acquisition limit

Resolved 4 November 2026Off-auction purchase (ToSTNeT-3)
Total acquisition price¥4,130,500,000 (maximum)
Maximum number of shares to be acquired1,100,000 shares (maximum)Common shares of the Company
2.64%Maximum number that can be acquired

The full horizontal line represents all issued shares, with marks at 10% intervals. The colored section represents the percentage stated in the resolution as the maximum proportion that may be repurchased under it.
This is a limit, and does not mean that the company will buy back all of it. The amount actually acquired will be shown in a later disclosure on the status of the acquisition of treasury shares.

Acquisition period

12 May 2026 to 31 December 2026

Reason for acquisition

Because the specific method of acquisition was decided

Amendment to resolution details
Change in acquisition limit1,300,000 shares (maximum), ¥6,000,000,000 (maximum) → 1,100,000 shares (maximum), ¥4,130,500,000 (maximum)(15.38% reduction in the number of shares; 31.16% reduction in the amount)
Change in acquisition period12 May 2026 to 31 December 2026 → Not disclosed
Reference (number of shares stated in the document)
Current number of treasury shares4,803,646 shares (as of 30 September 2026)
Total number of issued shares41,738,339 shares (excluding treasury shares, as of 30 September 2026)
Resolution on acquisition limit
ItemDetails
Class of shares to be acquiredCommon shares of the Company
Maximum number of shares to be acquired1,100,000 shares (maximum)
Percentage of total issued shares2.64%
Total acquisition price¥4,130,500,000 (maximum)
Acquisition period12 May 2026 to 31 December 2026
Method of acquisitionOff-auction purchase (ToSTNeT-3)
Reason for acquisitionBecause the specific method of acquisition was decided
Resolution date4 November 2026
Current number of treasury shares4,803,646 shares (as of 30 September 2026)
Total number of issued shares41,738,339 shares (excluding treasury shares, as of 30 September 2026)
Change in acquisition period12 May 2026 to 31 December 2026 → Not disclosed
Change in acquisition limit1,300,000 shares (maximum), ¥6,000,000,000 (maximum) → 1,100,000 shares (maximum), ¥4,130,500,000 (maximum)(15.38% reduction in the number of shares; 31.16% reduction in the amount)
Items this document does not state (4)
Number of shares to be retiredPercentage of total issued shares before retirementScheduled retirement dateTotal number of issued shares after retirement

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the specific method of acquisition was decided. No reason was stated for reducing the acquisition limit.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.